Current progress in tuberculosis chemotherapy

dc.contributor.author	Pan American Health Organization	en_US
dc.date.accessioned	2018
dc.date.available	2018
dc.date.issued	1980	es_ES
dc.identifier.uri	http://hist.library.paho.org/English/EPID12994.pdf	es_ES
dc.identifier.uri	https://iris.paho.org/handle/10665.2/38439
dc.description.abstract	BACTERIOLOGIC BASES OF SHORT-COURSE CHEMOTHERAPY. THE PURPOSE OF TUBERCULOSIS CHEMOTHERAPY IS TO STERILIZE LESIONS QUICKLY AND COMPLETELY, AND THE DRUGS ARE USED TO AVOID THE FAILURES CAUSED BY BACTERIAL RESISTANCE AND TO AVERT RELAPSES. DESPITE THE HIGH PROPORTION OF MUTANTS RESISTANT TO DRUGS AMONG WILD STRAINS OF TUBERCLE BACILLI, SELECTION OF RESISTANT BACILLI IS EASILY AVOIDED BY APPROPRIATE COMBINATIONS OF ACTIVE DRUGS, THAT IS, DRUGS TO WHICH THE BACILLI THE SENSITIVE	es_ES
dc.relation.ispartofseries	PAHO. Epidemiological Bulletin;1(1),1980	es_ES
dc.subject	Tuberculosis	es_ES
dc.subject	Rifampin	es_ES
dc.subject	América Latina	es_ES
dc.title	Current progress in tuberculosis chemotherapy	es_ES
dc.type	Journal articles	en_US
dc.rights.holder	Pan American Health Organization	en_US

Files in this item

Files	Size	Format	View
There are no files associated with this item.